Deal finalised for The BVA Family to join Ipsos
Headquartered in Paris, The BVA Family is the owner of brands including pack testing company PRS In Vivo, insight consultancies BVA in France and the UK’s BDRC, and Italian research business Doxa.
The deal was first mooted earlier this year, with Ipsos entering into exclusive negotiations in April.
The agreement has now been concluded after fulfilling all necessary regulatory requirements, including in-depth consultation with employee representatives in France and obtaining relevant competition authority approvals.
Ipsos France will now operate under the name Ipsos Bva, while the teams in Italy will use the name Ipsos Doxa. In the UK, BDRC will operate under the Ipsos brand.
Ben Page (pictured), chief executive at Ipsos, said: “We are delighted to welcome The BVA Family teams to Ipsos. They now benefit from our global infrastructure, and the opportunities our scale brings them, while our clients will have access to new, innovative solutions.
“With our strong cultural fit and complementary set of services, we are poised to deliver even greater value to the businesses and organisations we serve.”
Gerard Lopez and Pascal Gaudin, chairmen at The BVA Family, added: “We are pleased to join forces with Ipsos, one of the world leaders in market research.
“This partnership allows us to leverage its international presence and solid competencies, significantly enhancing our capabilities to provide cutting-edge analysis and understanding of society and markets to our clients.”

We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
0 Comments